Andrew Taylor
We are proud to announce a major milestone for Causaly: successfully passing ISO 27001 certification.
Causaly announces ISO 27001 certification
We are proud to announce a major milestone for Causaly: successfully passing ISO 27001 certification.
Andrew Taylor
Causaly, a world leader in R&D analytics that allows researchers and specialists to navigate the intricate landscape of research, today announced the appointment of Chris Tunnell as SVP of Global Sales
Andrew Taylor
Further Reading
Alex Meissner joins Causaly as VP Strategy & Business Operations
Causaly, a leader in R&D Analytics that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, announced today that it has added Alex Meissner to the management team as Vice President for Strategy & Business Operations
Causaly raises $17 million to accelerate biomedical research and discovery of scientific breakthroughs
Causaly, the London-based company that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, has raised $17 million from investors to grow its team and expand into new markets.
Covid-19: Causaly partners with UCL to accelerate coronavirus research
At Causaly we’re excited to announce a new partnership with University College London (UCL) to help accelerate research into the pandemic
Causaly raises $5m in Series A round led by Pentech Ventures
London, November 19 – Causaly, the AI company that is teaching computers to read, understand and interpret all biomedical knowledge ever published, is pleased to announce its series A funding round, which saw new and existing investors commit $4.8m into the company. Pentech Ventures led the round together with EBRD Venture Capital, with participation from existing investors Marathon Venture Capital as well as existing angel investors.